Clinical Trials Directory

Trials / Completed

CompletedNCT01772069

Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus:Focusing on Fibromyalgia

Status
Completed
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Systemic lupus erythematosus (SLE) patients show a high prevalence of fibromyalgia though rates vary considerably from one study to another (from 8.2% to 45%). Although fibromyalgia can bring out the disability in daily life, the majority of previous reports only ascertained no significant association between the presence of fibromyalgia and the severity of SLE. It is necessary to make unremitting effort to reduce the mortality and life-threatening disease flare-up due to SLE disease itself. Additionally, we think that physicians need to pay more attention to improve health-related quality of life (HRQoL) in the patients with SLE. HRQoL could be influenced by various factors such as depression, fibromyalgia, disease duration, disease activity and etc. To improve the HRQoL in SLE patients, it might be the clinically important and constructive theme to investigate that which is the most important factor among the fibromyalgia, depression, sleep quality, SLE activity and SLE duration. The objective of this study is to evaluate the degree of contribution of fibromyalgia for reduced HRQoL and to identify the status of managing fibromyalgia in Korean patients with SLE.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2015-05-01
Completion
2015-11-01
First posted
2013-01-21
Last updated
2017-02-02

Source: ClinicalTrials.gov record NCT01772069. Inclusion in this directory is not an endorsement.